Sunday, November 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 12, 2026

Sterling Infrastructure and Griffon have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
Sterling Infrastructure and Griffon have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – March 12, 2026 – Zacks Equity Research shares Sterling Infrastructure, Inc…
Opening lines of the source · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Griffon Corporation earns Zacks Rank #5 (Strong Sell)

    60% confidence
  • Signed backlog, unsigned awards, and future phase opportunities give visibility into a pool of work approaching $4.5 billion

    60% confidence
  • It is likely best to look elsewhere right now for a stock to buy in March regarding Griffon

    60% confidence
  • Five areas—AI data centers, semiconductor fabrication, manufacturing, e-commerce distribution centers, and power generation—could arguably become the growth engines of the entire U.S. economy

    60% confidence
  • Visa stock currently carries a Zacks Rank #3 (Hold)

    60% confidence
  • Investors looking for infrastructure stock providing long-term upside exposure to AI data centers, reshoring, e-commerce should consider buying Sterling Infrastructure now

    60% confidence
  • Sterling Infrastructure is projected to grow revenue and earnings by 25% in 2026

    60% confidence
  • Sterling Infrastructure earns Zacks Rank #1 (Strong Buy)

    60% confidence
  • More than half of consumers in Asia Pacific region are gearing up to travel internationally in the next few months

    60% confidence

Data points we hold from this source

Visa Inc. · pe ratio forward23.12 ratio
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Sources reconciled: no open conflicts right now.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,959
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,959 facts checked against source5,585 source documents archived
Query this data → isubstrate.com